US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

2.2000
-0.0400-1.79%

Close Nov 4 16:00 ET

3.15MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

213.11%4.92M

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

-62.91%217K

-Cash and cash equivalents

213.11%4.92M

-61.22%3.19M

-73.42%1.78M

-25.81%161K

76.52%1.57M

349.32%8.24M

78.26%6.71M

-62.91%217K

Receivables

----

--13K

--26K

--13K

----

--0

-Related party accounts receivable

----

--13K

--26K

--13K

----

--0

Current deferred assets

----

-8.28%310K

----

--338K

Other current assets

0.00%69K

-41.41%116K

-51.09%67K

-10.00%18K

-40.00%69K

60.98%198K

28.04%137K

-31.03%20K

Total current assets

199.40%4.99M

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

-16.42%575K

Non current assets

Related parties assets

----

--13K

--26K

--13K

----

--0

Total non current assets

--0

Total assets

199.40%4.99M

-60.81%3.31M

-72.97%1.85M

-12.70%502K

65.77%1.67M

331.85%8.45M

72.85%6.85M

-16.42%575K

Liabilities

Current liabilities

Payables

18.40%592K

77.01%662K

167.33%401K

38.27%560K

65.02%500K

-31.25%374K

-58.56%150K

7.14%405K

-accounts payable

-56.95%192K

-6.06%310K

-39.53%78K

-18.68%296K

52.22%446K

-33.06%330K

-57.57%129K

80.20%364K

-Due to related parties current

640.74%400K

700.00%352K

1,438.10%323K

543.90%264K

440.00%54K

-13.73%44K

-63.79%21K

-76.70%41K

Current accrued expenses

-73.56%340K

-94.24%243K

-68.12%198K

684.87%934K

1,344.94%1.29M

1,929.33%4.22M

404.88%621K

-29.17%119K

Other current liabilities

-99.20%47K

-92.78%413K

-77.54%586K

--3.3M

--5.87M

--5.72M

--2.61M

----

Current liabilities

-85.14%1.16M

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

-27.59%614K

Non current liabilities

Total non current liabilities

--0

Total liabilities

-85.14%1.16M

-86.68%1.41M

-66.58%1.2M

718.24%5.02M

1,819.41%7.81M

1,230.49%10.6M

603.14%3.58M

-27.59%614K

Shareholders'equity

Share capital

--0

--3K

--1K

-50.00%1K

--0

-common stock

--0

--3K

--1K

-50.00%1K

--0

-Preferred stock

--0

Retained earnings

-6.37%-97.96M

-8.15%-95.27M

-12.88%-90.93M

-12.87%-91.57M

-14.45%-92.09M

-10.30%-88.09M

-4.61%-80.55M

-6.62%-81.13M

Paid-in capital

18.40%102.72M

13.24%98.1M

9.53%92.51M

8.42%87.92M

7.03%86.76M

6.93%86.63M

4.98%84.46M

6.80%81.09M

Total stockholders'equity

189.28%4.76M

295.32%2.84M

-59.49%1.58M

-9,258.97%-3.65M

-992.31%-5.34M

-225.28%-1.45M

13.16%3.91M

75.63%-39K

Noncontrolling interests

-15.68%-937K

-33.05%-938K

-45.23%-928K

---872K

---810K

---705K

---639K

----

Total equity

162.27%3.83M

187.99%1.9M

-79.98%654K

-11,494.87%-4.52M

-1,127.76%-6.15M

-286.11%-2.16M

-5.36%3.27M

75.63%-39K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	213.11%4.92M	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M	-62.91%217K
-Cash and cash equivalents	213.11%4.92M	-61.22%3.19M	-73.42%1.78M	-73.42%1.78M	-25.81%161K	76.52%1.57M	349.32%8.24M	78.26%6.71M	78.26%6.71M	-62.91%217K
Receivables	----	----	----	----	--13K	--26K	--13K	----	----	--0
-Related party accounts receivable	----	----	----	----	--13K	--26K	--13K	----	----	--0
Current deferred assets	----	----	----	----	-8.28%310K	----	----	----	----	--338K
Other current assets	0.00%69K	-41.41%116K	-51.09%67K	-51.09%67K	-10.00%18K	-40.00%69K	60.98%198K	28.04%137K	28.04%137K	-31.03%20K
Total current assets	199.40%4.99M	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M	-16.42%575K
Non current assets
Related parties assets	----	----	----	----	--13K	--26K	--13K	----	----	--0
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	199.40%4.99M	-60.81%3.31M	-72.97%1.85M	-72.97%1.85M	-12.70%502K	65.77%1.67M	331.85%8.45M	72.85%6.85M	72.85%6.85M	-16.42%575K
Liabilities
Current liabilities
Payables	18.40%592K	77.01%662K	167.33%401K	167.33%401K	38.27%560K	65.02%500K	-31.25%374K	-58.56%150K	-58.56%150K	7.14%405K
-accounts payable	-56.95%192K	-6.06%310K	-39.53%78K	-39.53%78K	-18.68%296K	52.22%446K	-33.06%330K	-57.57%129K	-57.57%129K	80.20%364K
-Due to related parties current	640.74%400K	700.00%352K	1,438.10%323K	1,438.10%323K	543.90%264K	440.00%54K	-13.73%44K	-63.79%21K	-63.79%21K	-76.70%41K
Current accrued expenses	-73.56%340K	-94.24%243K	-68.12%198K	-68.12%198K	684.87%934K	1,344.94%1.29M	1,929.33%4.22M	404.88%621K	404.88%621K	-29.17%119K
Other current liabilities	-99.20%47K	-92.78%413K	-77.54%586K	-77.54%586K	--3.3M	--5.87M	--5.72M	--2.61M	--2.61M	----
Current liabilities	-85.14%1.16M	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M	-27.59%614K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-85.14%1.16M	-86.68%1.41M	-66.58%1.2M	-66.58%1.2M	718.24%5.02M	1,819.41%7.81M	1,230.49%10.6M	603.14%3.58M	603.14%3.58M	-27.59%614K
Shareholders'equity
Share capital	--0	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0	--0
-common stock	--0	--0	--3K	--3K	--1K	-50.00%1K	-50.00%1K	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-6.37%-97.96M	-8.15%-95.27M	-12.88%-90.93M	-12.88%-90.93M	-12.87%-91.57M	-14.45%-92.09M	-10.30%-88.09M	-4.61%-80.55M	-4.61%-80.55M	-6.62%-81.13M
Paid-in capital	18.40%102.72M	13.24%98.1M	9.53%92.51M	9.53%92.51M	8.42%87.92M	7.03%86.76M	6.93%86.63M	4.98%84.46M	4.98%84.46M	6.80%81.09M
Total stockholders'equity	189.28%4.76M	295.32%2.84M	-59.49%1.58M	-59.49%1.58M	-9,258.97%-3.65M	-992.31%-5.34M	-225.28%-1.45M	13.16%3.91M	13.16%3.91M	75.63%-39K
Noncontrolling interests	-15.68%-937K	-33.05%-938K	-45.23%-928K	-45.23%-928K	---872K	---810K	---705K	---639K	---639K	----
Total equity	162.27%3.83M	187.99%1.9M	-79.98%654K	-79.98%654K	-11,494.87%-4.52M	-1,127.76%-6.15M	-286.11%-2.16M	-5.36%3.27M	-5.36%3.27M	75.63%-39K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data